These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29754277)

  • 1. Proton Pump Inhibitor Use, H
    Paik JM; Rosen HN; Gordon CM; Curhan GC
    Calcif Tissue Int; 2018 Oct; 103(4):380-387. PubMed ID: 29754277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.
    Lochhead P; Hagan K; Joshi AD; Khalili H; Nguyen LH; Grodstein F; Chan AT
    Gastroenterology; 2017 Oct; 153(4):971-979.e4. PubMed ID: 28728964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers.
    Fan HP; Zhou Y; Chen ML; Qiu KH; Feng X; Zhou C; Zhu ML; Huang RZ; Hu TY
    Pharmacotherapy; 2024 Jul; 44(7):539-548. PubMed ID: 38899757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
    Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
    Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
    Ngwenya S; Simin J; Brusselaers N
    Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
    Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
    Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors, But Not H2-receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients.
    Lyu B; Jorgenson MR; Hansen KE; Djamali A; Astor BC
    Transplantation; 2020 Dec; 104(12):2609-2615. PubMed ID: 32058466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: risk of fractures with acid-suppressing medication.
    Kwok CS; Yeong JK; Loke YK
    Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
    Park JH; Song YM; Jung JH; Han K
    Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study.
    Chen CB; Lin M; Eurich DT; Johnson JA
    Clin Ther; 2016 Jun; 38(6):1392-1400. PubMed ID: 27061884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Acid Suppression Therapy Exposure and Fracture in Young Children.
    Malchodi L; Wagner K; Susi A; Gorman G; Hisle-Gorman E
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31175146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.
    Yu EW; Bauer SR; Bain PA; Bauer DC
    Am J Med; 2011 Jun; 124(6):519-26. PubMed ID: 21605729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.